DK0625048T4 - Syntese af human procollagener og collagener i rekombinant DNA-systemer - Google Patents

Syntese af human procollagener og collagener i rekombinant DNA-systemer

Info

Publication number
DK0625048T4
DK0625048T4 DK92924122T DK92924122T DK0625048T4 DK 0625048 T4 DK0625048 T4 DK 0625048T4 DK 92924122 T DK92924122 T DK 92924122T DK 92924122 T DK92924122 T DK 92924122T DK 0625048 T4 DK0625048 T4 DK 0625048T4
Authority
DK
Denmark
Prior art keywords
collagen
collagens
synthesis
recombinant dna
human
Prior art date
Application number
DK92924122T
Other languages
Danish (da)
English (en)
Other versions
DK0625048T3 (da
Inventor
Darwin J Prockop
Andrzej Fertala
Aleksander Sieron
Kari I Kivirikko
Amy Geddis
Taina A Pihlajaniemi
Leena Ala-Kokko
Original Assignee
Fibrogen Inc
Univ Jefferson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25121036&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0625048(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fibrogen Inc, Univ Jefferson filed Critical Fibrogen Inc
Publication of DK0625048T3 publication Critical patent/DK0625048T3/da
Application granted granted Critical
Publication of DK0625048T4 publication Critical patent/DK0625048T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/11—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors (1.14.11)
    • C12Y114/11002—Procollagen-proline dioxygenase (1.14.11.2), i.e. proline-hydroxylase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
DK92924122T 1991-10-23 1992-10-22 Syntese af human procollagener og collagener i rekombinant DNA-systemer DK0625048T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78089991A 1991-10-23 1991-10-23
PCT/US1992/009061 WO1993007889A1 (en) 1991-10-23 1992-10-22 Synthesis of human procollagens and collagens in recombinant dna systems

Publications (2)

Publication Number Publication Date
DK0625048T3 DK0625048T3 (da) 2000-05-29
DK0625048T4 true DK0625048T4 (da) 2006-02-20

Family

ID=25121036

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92924122T DK0625048T4 (da) 1991-10-23 1992-10-22 Syntese af human procollagener og collagener i rekombinant DNA-systemer

Country Status (11)

Country Link
US (1) US5405757A (de)
EP (2) EP0962529A1 (de)
JP (2) JP3302017B2 (de)
AT (1) ATE188253T1 (de)
AU (2) AU680606B2 (de)
CA (1) CA2121698C (de)
DE (1) DE69230502T3 (de)
DK (1) DK0625048T4 (de)
ES (1) ES2143478T5 (de)
GR (1) GR3033022T3 (de)
WO (1) WO1993007889A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020142391A1 (en) * 1991-06-12 2002-10-03 Kivirikko Kari I. Synthesis of human procollagens and collagens in recombinant DNA systems
US6653450B1 (en) * 1993-01-28 2003-11-25 Cohesion Technologies, Inc. Mutated recombinant collagens
US5667839A (en) * 1993-01-28 1997-09-16 Collagen Corporation Human recombinant collagen in the milk of transgenic animals
AU674798B2 (en) * 1993-10-25 1997-01-09 Teijin Limited Purified human chondrocalcin, process for producing the same, and utilization thereof
CA2189421A1 (en) * 1994-05-11 1995-11-23 Organogenesis Inc. Collagen from cell cultures
US6713662B1 (en) * 1994-07-27 2004-03-30 Pharming Intellectual Property B.V. Production of collagen in the milk of transgenic mammals
KR19990036272A (ko) * 1995-08-08 1999-05-25 사우코넨 주시 제이 재조합 ｃ-프로테나제와 이의 공정, 제조방법 및 이의 용도
PT859838E (pt) 1995-08-31 2003-10-31 Univ Manchester Novos procolagenios
AU7450496A (en) * 1995-10-20 1997-05-07 Collagen Corporation Production of recombinant procollagen in yeast
EP0861086A1 (de) * 1995-11-13 1998-09-02 Fibrogen, Inc. Typ ix kollagen und chimere
US5773248A (en) * 1995-11-13 1998-06-30 Uab Research Foundation Nucleic acid encoding a human α3(IX) collagen protein and method of producing the protein recombinantly
AU3056697A (en) * 1996-04-12 1997-11-07 Academy Of Finland Synthesis of human procollagens and collagens in recombinant dna systems
US5856308A (en) * 1996-09-27 1999-01-05 Haemacure Corporation Artificial collagen
AUPO331096A0 (en) * 1996-10-29 1996-11-21 Commonwealth Scientific And Industrial Research Organisation Collagen products
DE69738967D1 (de) * 1996-10-29 2008-10-16 Commw Scient Ind Res Org Stabile expression von tripelhelikalen proteinen
AU780813B2 (en) * 1996-10-29 2005-04-21 Commonwealth Scientific And Industrial Research Organisation Stable expression of triple helical proteins
FR2757874B1 (fr) * 1996-12-17 2003-04-25 Biocem Collagenes recombinants et proteines derivees produits par les plantes, leurs procedes d'obtention et leurs utilisations
GB9704305D0 (en) * 1997-03-01 1997-04-23 Univ Manchester Procollagen assembly
NL1007908C2 (nl) * 1997-12-24 1999-06-25 Fuji Photo Film Bv Zilverhalide-emulsies met recombinant collageen die geschikt zijn voor fotografische toediening alsmede de bereiding daarvan.
US6150081A (en) 1997-12-24 2000-11-21 Fuji Photo Film B.V. Silver halide emulsions with recombinant collagen suitable for photographic application and also the preparation thereof
DE19812713A1 (de) * 1998-03-24 1999-09-30 Merck Patent Gmbh Verfahren zur Herstellung von mineralisierten Kollagenfibrillen und deren Verwendung als Knochenersatzwerkstoff
JP2000125872A (ja) * 1998-09-07 2000-05-09 Terumo Corp 三量体キメラタンパク質およびキメラタンパク質を含有するコラーゲンマトリックス
IL149459A0 (en) * 1999-11-12 2002-11-10 Fibrogen Inc Recombinant gelatins
BR0015507A (pt) * 1999-11-12 2002-10-22 Fibrogen Inc Gelatinas e colágenos animais
WO2003093314A2 (en) 2002-05-03 2003-11-13 Millenium Biologix Inc. Connective tissue stimulating peptides
MXPA05002669A (es) 2002-09-13 2005-08-19 Ocular Sciences Inc Dispositivos y metodos para mejorar la vision.
GB0309064D0 (en) 2003-04-22 2003-05-28 Univ Manchester Modified peptides and their uses
EP1771131A2 (de) 2004-05-20 2007-04-11 CooperVision Inc. Hornhaut-onlays und wellenfrontaberrationskorrektion zur verbesserung des visus
CN101171334B (zh) * 2005-03-31 2013-03-27 扶桑药品工业株式会社 具有三螺旋结构的蛋白质的生产方法，生产所述蛋白的cho细胞和试剂盒
AU2012200573B2 (en) * 2005-03-31 2013-11-07 Fuso Pharmaceutical Industries, Ltd. "Process for production of protein having triple-helical structure"
CA2876767C (en) 2005-10-03 2018-07-10 Mark A. Pinsky Liposomes comprising hyaluronic acid and their use in improved skin care
US20080081353A1 (en) * 2006-09-29 2008-04-03 Universite Laval Production of recombinant human collagen
EP2222270B1 (de) 2007-12-26 2018-11-14 Mark A. Pinsky Collagenformulierungen für verbesserte hautpflege
US9095569B2 (en) * 2008-04-18 2015-08-04 Collplant Ltd. Methods of generating and using procollagen
DK2380979T3 (da) 2008-12-22 2015-06-22 Univ Hokkaido Nat Univ Corp Proteinstof med trippelhelixstruktur samt fremgangsmåde til dets fremstilling
EP2701508A4 (de) * 2011-04-26 2015-01-07 Univ Leland Stanford Junior Herstellung und abgabe eines stabilen kollagens
US20140066379A1 (en) * 2012-08-30 2014-03-06 Body Organ Biomedical Corp. Recombinant vector, transgenic fish egg using the same and biomaterial using the same
FR3033697B1 (fr) * 2015-03-17 2020-03-27 Universite Pierre Et Marie Curie (Paris 6) Suspensions de collagene injectables, leur procede de preparation et leurs utilisations, notamment pour la formation de matrices denses de collagene
US20230148256A1 (en) * 2019-05-14 2023-05-11 Provenance Bio, Llc Expression of modified proteins in a peroxisome
KR102135976B1 (ko) * 2019-10-24 2020-07-20 주식회사 에이바이오테크 콜라겐 합성 촉진 활성을 갖는 펩타이드 및 이를 이용한 방법
DE102021202830A1 (de) 2021-03-23 2022-09-29 Gelita Ag Rekombinantes Typ II-Kollagen zur therapeutischen Verwendung
WO2023194333A1 (en) 2022-04-04 2023-10-12 Swiftpharma Bv Recombinant spider silk-reinforced collagen proteins produced in plants and the use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4645748A (en) * 1985-02-01 1987-02-24 Charles Hurwitz Protein which is characteristic of rheumatoid arthritis
US4840793A (en) * 1987-06-11 1989-06-20 Dana-Farber Cancer Institute Method of reducing tissue damage at an inflammatory site using a monoclonal antibody
US5147638A (en) * 1988-12-30 1992-09-15 Oklahoma Medical Research Foundation Inhibition of tumor growth by blockade of the protein C system
US5045449A (en) * 1989-06-14 1991-09-03 Thomas Jefferson University Methods of detecting a genetic predisposition for vascular aneurysms
US5136021A (en) * 1990-02-27 1992-08-04 Health Research, Inc. TNF-inhibitory protein and a method of production

Also Published As

Publication number Publication date
AU4441497A (en) 1998-02-12
DE69230502T2 (de) 2000-08-10
EP0625048B2 (de) 2005-10-26
AU680606B2 (en) 1997-08-07
WO1993007889A1 (en) 1993-04-29
EP0625048A4 (de) 1995-04-05
ES2143478T3 (es) 2000-05-16
US5405757A (en) 1995-04-11
ATE188253T1 (de) 2000-01-15
ES2143478T5 (es) 2006-05-16
JPH07501939A (ja) 1995-03-02
EP0625048B1 (de) 1999-12-29
DK0625048T3 (da) 2000-05-29
AU3055592A (en) 1993-05-21
CA2121698C (en) 2010-05-18
DE69230502T3 (de) 2006-05-24
DE69230502D1 (de) 2000-02-03
HK1010334A1 (en) 1999-06-17
EP0962529A1 (de) 1999-12-08
JP3302017B2 (ja) 2002-07-15
EP0625048A1 (de) 1994-11-23
CA2121698A1 (en) 1993-04-29
JP2002255999A (ja) 2002-09-11
GR3033022T3 (en) 2000-08-31

Similar Documents

Publication Publication Date Title
DK0625048T4 (da) Syntese af human procollagener og collagener i rekombinant DNA-systemer
DK0568537T3 (da) Genetisk modificering af endotelceller
DE69333731D1 (de) Glialmitogene faktoren, ihre herstellung und verwendung
DE69228118D1 (de) Bmp-9 zusammensetzungen
ES2128330T3 (es) Material para la substitucion de huesos con factores de crecimiento de fibroblastos.
DE69528058D1 (de) Bmp-9 zusammensetzungen
DE69722681D1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen darmerkrankungen
EP0846262A4 (de) Abbildung von spektroskopie von gewebe und anderen stark streuenden medien, basierend auf fluoreszenz lebensdauer
BR9406716A (pt) Molécula de DNA isolada célula hospedeira vetor método para produzir uma proteina (BMP-10) polipeptideo de proteina-10 morfogenética de osso purificada (BMP-10) e molécula de DNA quimérica
DE69637256D1 (de) Synthese von Methoxynukleoside und enzymatische Nukleisäure Moleküle
DE69233022D1 (de) Rekombinante knochenmorphogenetische protein heterodimere, zusammensetzungen und verfahren zur verwendung
DE59611411D1 (de) Verwendung von alpha 1l-agonisten zur behandlung der harninkontinenz
DE69901524D1 (de) Kosmetische Zusammensetzung enthaltend ein anionisches Polymer und ein acrylisches Terpolymer und Verwendung dieser Zusammensetzung zur Behandlung von Keratinfasern
PT1690874E (pt) Bmp-12, bmp-13 e suas composições indutoras de tendões
DE69726884D1 (de) Menschliches sdf-5 protein und diesbezügliche zusammensetzungen
DK1237549T3 (da) Lipoxin A4 og dets analoger til behandling af törre öjne
DK1028744T3 (da) Neuronale anvendelser af BMP-11
BR0014183A (pt) Composições farmaceuticas e metodos de uso de proteìna relacionada frizzled secretada
ATE79031T1 (de) Verwendung von ketonderivaten zur behandlung von depressionen.
PT1007559E (pt) Celulas geneticamente modificadas que expressam as proteinas morfogeneticas do osso
ATE233553T1 (de) Mono-und disulfosubstituierte anthrachinone und deren verwendung zur behandlung von knochenmatrixerkrankungen
ATE222901T1 (de) Carboxylsubstituierte chromanderivate zur verwendung als beta 3 adrenorezeptor-agonisten
DE69735039D1 (de) Acetylhydrolase des Plättchen aktivierenden Faktors, und entsprechendes Gen
ATE113591T1 (de) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol- - one und ihre verwendung als antikonvulsiva.
ATE190630T1 (de) Angiotensin-ii typ-1 rezeptor und dessen herstellung